Investment
Features
FeesSafety
Academy
More
Pluang+

Compare United Parcel Service Inc (UPS) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

United Parcel Service IncTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

United Parcel Service Inc vs Zimmer Biomet Holdings Inc — how do they compare? United Parcel Service Inc trades at $103.42 (market cap $88.85B), while Zimmer Biomet Holdings Inc trades at $95.77 (market cap $18.55B). The key difference: United Parcel Service Inc is far larger — about 4.8× Zimmer Biomet Holdings Inc's market cap, and United Parcel Service Inc pays the higher dividend (6.28%). Which is the better fit depends on your goals.

UPSZBH
Market Cap
$88.85B$18.55B
Volume
2,288,643
Sector
IndustrialsHealth
52-Week High
$120.00$107.71
52-Week Low
$82.58$79.58
Enterprise Value
$112.87B$25.61B
Dividend Yield
6.28%0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

United Parcel Service Inc

UPS trades at $104.71, up 0.22% on the day, with a bearish technical signal but strong fundamentals including a 29.66% ROE and consistent earnings beats. Revenue has declined from $100.3B in 2022 to $88.7B in 2025, though Q2 2026 showed a 7.6% YoY increase. The company maintains a solid dividend yield of 6.3% and is executing a strategic shift away from low-margin Amazon volume.

The outlook is mixed; analyst consensus is a Buy with a $117.90 price target, but technicals and declining net income pose risks. Opportunities include margin improvement from automation and healthcare logistics, while risks involve high dividend payout relative to free cash flow and economic sensitivity.

Zimmer Biomet Holdings Inc

ZBH trades at $97.78, up 1.27% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and raised its 2026 outlook. Revenue growth remains steady at 4.8% year-over-year, though net income margin has moderated from 2023 peaks. Analyst consensus is a 'Buy' with a $103.56 price target, indicating modest upside potential from current levels.

The stock offers a balanced risk-reward profile with solid fundamentals and positive momentum, but faces headwinds from margin pressure and rising debt levels. Investors should weigh the strong institutional support and consistent earnings performance against competitive pressures and macroeconomic uncertainties affecting the medtech sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About United Parcel Service Inc

United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network

Read more on UPS

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH